AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7835209 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibratory stimulation for 5 minutes
Number of subjects: 59
Study 7835209 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 59
Study 7835209 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 59
Study 31187169 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib 2000 mg
Number of subjects: 37
Study 31187169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 29027884 — intervention group
Group type: EXPERIMENTAL
Intervention: Handheld, nonmydriatic fundus camera (Pictor Plus; Volk Optical, Mentor, OH)
Number of subjects: 109
Study 27466884 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-loss diets with different macronutrient compositions
Number of subjects: 711
Study 25232119 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) activating anterior‐to‐posterior (AP) inputs
Number of subjects: 0
Study 25232119 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) activating posterior‐to‐anterior (PA) inputs
Number of subjects: 0
Study 22270979 — intervention group
Group type: EXPERIMENTAL
Intervention: Billroth I (B-I)
Number of subjects: 332
Study 22270979 — intervention group
Group type: COMPARATOR
Intervention: Roux-en-Y (R-Y)
Number of subjects: 332
Study 20879641 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention providing specific dietary advice and ongoing motivational support during routine antenatal appointments
Number of subjects: 25
Study 18596681 — intervention group
Group type: EXPERIMENTAL
Intervention: Pumped before drinking (PB)
Number of subjects: 16
Study 18596681 — intervention group
Group type: EXPERIMENTAL
Intervention: Pumped after drinking (PA)
Number of subjects: 16
Study 15826053 — intervention group
Group type: EXPERIMENTAL
Intervention: Phloem-fortified rye bread (62 mg catechins, high polyphenol, HP)
Number of subjects: 75
Study 15826053 — intervention group
Group type: EXPERIMENTAL
Intervention: Phloem-fortified rye bread (31 mg catechins, low polyphenol, LP)
Number of subjects: 75
Study 15826053 — intervention group
Group type: COMPARATOR
Intervention: Rye bread (placebo)
Number of subjects: 75
Study 12860804 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye black grease
Number of subjects: 46
Study 12860804 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiglare stickers
Number of subjects: 46
Study 12860804 — intervention group
Group type: COMPARATOR
Intervention: Control (Petroleum jelly)
Number of subjects: 46
Study 10391656 — intervention group
Group type: EXPERIMENTAL
Intervention: Studies meeting methodological quality criteria (explicit statement of random allocation, allocation concealment, double-blinding, completeness of follow-up)
Number of subjects: 89
Study 10391656 — intervention group
Group type: EXPERIMENTAL
Intervention: Studies scoring above predefined scores in quality assessment scales
Number of subjects: 89
Study 10391656 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative meta-analysis of studies with lower-quality scores
Number of subjects: 89
Study 10391656 — intervention group
Group type: EXPERIMENTAL
Intervention: Studies with better methodological quality
Number of subjects: 89
Study 8554205 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy
Number of subjects: 153
Study 8554205 — intervention group
Group type: COMPARATOR
Intervention: Standard insulin therapy
Number of subjects: 153
Study 1876626 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg daily
Number of subjects: 11
Study 1876626 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 6125185 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg
Number of subjects: 12
Study 6125185 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 60 mg
Number of subjects: 12
Study 6125185 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol 20 mg
Number of subjects: 12
Study 6125185 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol 5 mg
Number of subjects: 12
Study 6125185 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (inhaled)
Number of subjects: 12
Study 6125185 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine (inhaled)
Number of subjects: 12
Study 6125185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30439998 — intervention group
Group type: EXPERIMENTAL
Intervention: New ergonomic wrap
Number of subjects: 96
Study 30439998 — intervention group
Group type: COMPARATOR
Intervention: Traditional wrap
Number of subjects: 96
Study 26666236 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow cell therapy
Number of subjects: 83
Study 26666236 — intervention group
Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 83
Study 25463819 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish instruction for 6 months
Number of subjects: 55
Study 25463819 — intervention group
Group type: COMPARATOR
Intervention: Introductory Psychology (control group)
Number of subjects: 55
Study 22615116 — intervention group
Group type: EXPERIMENTAL
Intervention: Home blood pressure telemonitoring with self-care support
Number of subjects: 110
Study 22615116 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 110
Study 22615116 — intervention group
Group type: COMPARATOR
Intervention: Home blood pressure monitoring alone
Number of subjects: 110
Study 20666265 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg/day
Number of subjects: 90
Study 20666265 — intervention group
Group type: COMPARATOR
Intervention: Placebo (routine group)
Number of subjects: 90
Study 19102428 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.8-mm GIA universal stapler
Number of subjects: 60
Study 19102428 — intervention group
Group type: COMPARATOR
Intervention: 3.5-mm GIA universal stapler
Number of subjects: 60
Study 16260243 — intervention group
Group type: EXPERIMENTAL
Intervention: Audience response system interactive lectures
Number of subjects: 17
Study 16260243 — intervention group
Group type: COMPARATOR
Intervention: Standard lecture
Number of subjects: 17
Study 11804978 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fibrinolysis with alteplase
Number of subjects: 19
Study 11804978 — intervention group
Group type: COMPARATOR
Intervention: Revascularization by stent placement with additional abciximab treatment
Number of subjects: 19
Study 10546605 — intervention group
Group type: EXPERIMENTAL
Intervention: Midvastus approach
Number of subjects: 109
Study 10546605 — intervention group
Group type: COMPARATOR
Intervention: Medial parapatellar approach
Number of subjects: 109
Study 7552860 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (400 mg orally, four times daily for 15 days)
Number of subjects: 10
Study 7552860 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 15374509 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrolysin + multivitamin infusions
Number of subjects: 27
Study 15374509 — intervention group
Group type: COMPARATOR
Intervention: Multivitamin infusions alone
Number of subjects: 27
Study 6156059 — intervention group
Group type: EXPERIMENTAL
Intervention: IV gamma-globulin (GG) 20 g IV given postoperatively
Number of subjects: 0
Study 31375380 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (a‐tDCS) at 2 mA for 30 minutes
Number of subjects: 24
Study 31375380 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 24
Study 30465722 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.15 mg/kg)
Number of subjects: 118
Study 30465722 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 27006178 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus radiotherapy/temozolomide
Number of subjects: 225
Study 27006178 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 225
Study 24568258 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Stabilization Training (FST)
Number of subjects: 31
Study 24568258 — intervention group
Group type: COMPARATOR
Intervention: Standard Training
Number of subjects: 31
Study 23338260 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% hydrogen peroxide (HP) for 10 min
Number of subjects: 52
Study 23338260 — intervention group
Group type: EXPERIMENTAL
Intervention: 24% hydrogen peroxide (HP) for 1 min
Number of subjects: 52
Study 23338260 — intervention group
Group type: EXPERIMENTAL
Intervention: Airborne-particle abrasion (Al(2)O(3))
Number of subjects: 52
Study 23338260 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 52
Study 20054294 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaglinide treatment for 8 weeks
Number of subjects: 259
Study 20054294 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 259
Study 18616772 — intervention group
Group type: EXPERIMENTAL
Intervention: Ion-exchange water softeners
Number of subjects: 310
Study 15578769 — intervention group
Group type: EXPERIMENTAL
Intervention: Tensotin (Julphar, UAE)
Number of subjects: 24
Study 15578769 — intervention group
Group type: COMPARATOR
Intervention: Tenormin (Zeneca, UK)
Number of subjects: 24
Study 14609970 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy plus gradual tapering of benzodiazepines (combined treatment)
Number of subjects: 65
Study 14609970 — intervention group
Group type: COMPARATOR
Intervention: Gradual tapering of benzodiazepines only (control group)
Number of subjects: 65
Study 10762517 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulant treatment
Number of subjects: 47
Study 10762517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 8618283 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (2 cycles of 70 mg/m² cisplatin and 30 mg/m² doxorubicin with a 3-week interval)
Number of subjects: 325
Study 8618283 — intervention group
Group type: COMPARATOR
Intervention: Control (no chemotherapy)
Number of subjects: 325
Study 8618283 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 325
Study 1414144 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐DAMME (0.25 mg iv)
Number of subjects: 9
Study 1414144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 4022581 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (1% prednisolone acetate) in Group 2
Number of subjects: 75
Study 4022581 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic prednisone in Group 3
Number of subjects: 75
Study 4022581 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 1) with cycloplegic and topical antibiotic only
Number of subjects: 75
Study 31219033 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate postoperative radiotherapy
Number of subjects: 131
Study 31219033 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy on progression
Number of subjects: 131
Study 31219033 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete resection
Number of subjects: 131
Study 31219033 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative involvement of, or operative damage to, the hypothalamus
Number of subjects: 131
Study 30584418 — intervention group
Group type: EXPERIMENTAL
Intervention: T2T strategy
Number of subjects: 346
Study 27176121 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable Video Media (PVM)
Number of subjects: 72
Study 27176121 — intervention group
Group type: COMPARATOR
Intervention: Standard Verbal Communication (SVC)
Number of subjects: 72
Study 24251579 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glucose control (addition of an oral glucose-lowering agent or commencement of insulin)
Number of subjects: 11140
Study 24251579 — intervention group
Group type: COMPARATOR
Intervention: Standard glucose control
Number of subjects: 11140
Study 24251579 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of an oral glucose-lowering agent
Number of subjects: 11140
Study 24251579 — intervention group
Group type: EXPERIMENTAL
Intervention: Commencement of insulin
Number of subjects: 11140
Study 22189652 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating-water leg wraps combined with a full-length circulating-water mattress set at 42°C
Number of subjects: 36
Study 22189652 — intervention group
Group type: COMPARATOR
Intervention: Forced-air warming system set on high (≈43°C)
Number of subjects: 36
Study 22189652 — intervention group
Group type: COMPARATOR
Intervention: Carbon-fiber resistive-heating system set at 42°C
Number of subjects: 36
Study 20654695 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (12 min)
Number of subjects: 53
Study 20654695 — intervention group
Group type: COMPARATOR
Intervention: Control condition (movie watching)
Number of subjects: 53
Study 17931940 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% ethylenediaminetetraacetic acid for 3 minutes
Number of subjects: 52
Study 17931940 — intervention group
Group type: EXPERIMENTAL
Intervention: Cr, Er: YSGG laser treatment for 40 seconds
Number of subjects: 52
Study 17931940 — intervention group
Group type: COMPARATOR
Intervention: Control group (no further treatment)
Number of subjects: 52
Study 16336069 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss program (BWLP)
Number of subjects: 40
Study 12044126 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal cocaine (2 mg/kg of body weight)
Number of subjects: 7
Study 12044126 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lidocaine, 2 mg/kg)
Number of subjects: 7
Study 10448262 — intervention group
Group type: EXPERIMENTAL
Intervention: Onapristone 100 mg/day
Number of subjects: 19
Study 7884433 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-3 5 micrograms/kg/d
Number of subjects: 17
Study 7884433 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-3 10 micrograms/kg/d
Number of subjects: 17
Study 7884433 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin and cyclophosphamide combination therapy
Number of subjects: 17
Study 2086422 — intervention group
Group type: EXPERIMENTAL
Intervention: Honan Oculopressor
Number of subjects: 32
Study 2086422 — intervention group
Group type: COMPARATOR
Intervention: Suction-cup oculodynamometer
Number of subjects: 32
Study 2086422 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Honan Oculopressor and Suction-cup oculodynamometer
Number of subjects: 32
Study 2086422 — intervention group
Group type: COMPARATOR
Intervention: Comparison between age groups
Number of subjects: 32
Study 32961 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 50
Study 32961 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 50
Study 31652030 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified language with mediation
Number of subjects: 60
Study 31652030 — intervention group
Group type: COMPARATOR
Intervention: Complex text with mediation
Number of subjects: 60
Study 31652030 — intervention group
Group type: COMPARATOR
Intervention: Simplified language without mediation
Number of subjects: 60
Study 31652030 — intervention group
Group type: COMPARATOR
Intervention: Complex text without mediation
Number of subjects: 60
Study 31172276 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric Sleep Questionnaire (PSQ)
Number of subjects: 100
Study 31172276 — intervention group
Group type: EXPERIMENTAL
Intervention: OSA-18
Number of subjects: 100
Study 31172276 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analyses
Number of subjects: 100
Study 31172276 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysomnography
Number of subjects: 100
Study 28294535 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA)
Number of subjects: 62
Study 28294535 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous fat
Number of subjects: 62
Study 25486542 — intervention group
Group type: EXPERIMENTAL
Intervention: Illuminated microcatheter‐assisted trabeculotomy (Group I)
Number of subjects: 30
Study 25486542 — intervention group
Group type: COMPARATOR
Intervention: Combined trabeculotomy with trabeculectomy augmented with mitomycin C (Group II)
Number of subjects: 30
Study 23895252 — intervention group
Group type: COMPARATOR
Intervention: Cancellous allograft (CAN group)
Number of subjects: 28
Study 23895252 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancellous allograft mixed with PRP (PRP group)
Number of subjects: 28
Study 22591551 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic biodanza
Number of subjects: 70
Study 22591551 — intervention group
Group type: COMPARATOR
Intervention: Stretching exercises
Number of subjects: 70
Study 19509014 — intervention group
Group type: EXPERIMENTAL
Intervention: PREDIAS group program
Number of subjects: 182
Study 19509014 — intervention group
Group type: COMPARATOR
Intervention: Control group (written information about diabetes prevention)
Number of subjects: 182
Study 17577460 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with doxazosin and finasteride
Number of subjects: 0
Study 17577460 — intervention group
Group type: COMPARATOR
Intervention: Doxazosin monotherapy
Number of subjects: 0
Study 17577460 — intervention group
Group type: COMPARATOR
Intervention: Finasteride monotherapy
Number of subjects: 0
Study 15102012 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of INR
Number of subjects: 163
Study 15102012 — intervention group
Group type: EXPERIMENTAL
Intervention: Full patient self-management
Number of subjects: 163
Study 15102012 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved patient education
Number of subjects: 163
Study 15102012 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 163
Study 12378041 — intervention group
Group type: EXPERIMENTAL
Intervention: Linseed diet (5% extruded linseed in livestock diet)
Number of subjects: 75
Study 12378041 — intervention group
Group type: COMPARATOR
Intervention: Standard diet (control group)
Number of subjects: 75
Study 10326113 — intervention group
Group type: EXPERIMENTAL
Intervention: DHF
Number of subjects: 52
Study 10326113 — intervention group
Group type: COMPARATOR
Intervention: DF
Number of subjects: 52
Study 7653825 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (n = 21)
Number of subjects: 41
Study 7653825 — intervention group
Group type: COMPARATOR
Intervention: Enflurane (n = 20)
Number of subjects: 41
Study 2551088 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic low-dose heparin/dihydroergotamine
Number of subjects: 120
Study 2551088 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular heparin/dihydroergotamine
Number of subjects: 120
Study 2551088 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 7318622 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-gut irrigation
Number of subjects: 100
Study 7318622 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical bowel preparation
Number of subjects: 100
Study 7318622 — intervention group
Group type: COMPARATOR
Intervention: Conventional preparation
Number of subjects: 100
Study 31682586 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model based on long short-term memory-based recurrent neural networks for forecasting glucose levels
Number of subjects: 10
Study 27864724 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic single-site cholecystectomy (RSSC)
Number of subjects: 136
Study 27864724 — intervention group
Group type: COMPARATOR
Intervention: Multiport laparoscopic cholecystectomy (MPLC)
Number of subjects: 136
Study 25541524 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane/remifentanil anesthesia
Number of subjects: 21
Study 25541524 — intervention group
Group type: COMPARATOR
Intervention: Propofol/remifentanil anesthesia
Number of subjects: 21
Study 24032547 — intervention group
Group type: EXPERIMENTAL
Intervention: BAS (titanium-nitride-oxide-coated bioactive stents)
Number of subjects: 827
Study 24032547 — intervention group
Group type: COMPARATOR
Intervention: EES (everolimus-eluting stents)
Number of subjects: 827
Study 21429234 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention group (n = 27)
Number of subjects: 54
Study 21429234 — intervention group
Group type: COMPARATOR
Intervention: Close follow-up group (n = 27)
Number of subjects: 54
Study 19693492 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (1 mg/day)
Number of subjects: 12
Study 19693492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 19043994 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma Risk Management (TRiM) system
Number of subjects: 0
Study 15231554 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Psychodynamic Supportive Psychotherapy
Number of subjects: 191
Study 15231554 — intervention group
Group type: COMPARATOR
Intervention: Combined therapy (psychotherapy + antidepressants)
Number of subjects: 191
Study 11277173 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human thrombopoietin (rhTPO) administered intravenously by bolus injection at doses ranging from 0.3 to 4.8 microg/kg/day every 3 days and 0.6 microg/kg daily to three patients.
Number of subjects: 30
Study 11277173 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF administered concomitantly to promote myeloid recovery.
Number of subjects: 30
Study 9863499 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of four virostatics affecting four targets
Number of subjects: 10
Study 9863499 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of three virostatics affecting three targets
Number of subjects: 10
Study 9863499 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter (3 week) sequences of drug combinations
Number of subjects: 10
Study 9863499 — intervention group
Group type: EXPERIMENTAL
Intervention: CD4 count
Number of subjects: 10
Study 8307046 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 2 g once daily for two days
Number of subjects: 36
Study 8307046 — intervention group
Group type: COMPARATOR
Intervention: Penicillin G standard regimen for six days
Number of subjects: 36
Study 3721103 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventricular late potentials identified in 28 patients (51%) 4-8 days after MI; mean duration was 75 +/- 33 msec.
Number of subjects: 55
Study 3721103 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of late potentials showed 75% sensitivity with predictive value of 32%.
Number of subjects: 55